日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Targeting Bladder Cancer with Inactivated Uropathogenic E. coli: A Novel Alternative to BCG Immunotherapy

利用灭活的致病性大肠杆菌靶向治疗膀胱癌：一种新型的卡介苗免疫疗法替代方案

期刊:Cells
影响因子:5.2
doi:10.3390/cells15030229
Yutkin, Vladimir; Maalouf, Naseem; Gur, Chamutal; Zini, Avraham; Bachrach, Gilad; Mandelboim, Ofer
肿瘤
肿瘤免疫
膀胱癌
免疫/内分泌
发表日期：2026
文献求助 收藏

Eosinophils but not mast cells exert anti-tumorigenic activity, without being predictive markers of the long-term response to Bacillus Calmette-Guérin (BCG) therapy in patients with bladder carcinoma.

嗜酸性粒细胞（而非肥大细胞）具有抗肿瘤活性，但不能预测膀胱癌患者对卡介苗（BCG）治疗的长期反应

期刊:Inflammation Research
影响因子:5.4
doi:10.1007/s00011-025-02028-1
Zaffran Ilan, Zoabi Yara, Gaur Pratibha, Alekberli Fidan Rahimli, Tiligada Ekaterini, Yutkin Vladimir, Levi-Schaffer Francesca
肿瘤
发表日期：2025
文献求助 收藏

The relevance of nomograms for prediction of pelvic lymph node metastases in the prostate-specific membrane antigen (PSMA)-PET/CT era

在PSMA-PET/CT时代，列线图在预测盆腔淋巴结转移中的应用价值

期刊:Current Urology
影响因子:1.3
doi:10.1097/CU9.0000000000000290
Gofrit, Ofer N; Orevi, Marina; Ben-Haim, Simona; Meuman, Tzahi; Duvdevani, Mordechai; Hidas, Guy; Yutkin, Vladimir
发表日期：2025
文献求助 收藏

Quantifying treatment burden: the patient burden score a study of 758 patients across three clinical urologic scenarios

量化治疗负担：患者负担评分——一项涵盖三种泌尿外科临床情景的758例患者的研究

期刊:World Journal of Urology
影响因子:2.9
doi:10.1007/s00345-024-05378-3
Gofrit, Ofer N; Goldberg, S Nahum; Lorber, Amitay; Duvdevani, Mordechai; Wygoda, Marc; Hidas, Guy; Yutkin, Vladimir; Pikarsky, Liat Appelbaum
发表日期：2024
文献求助 收藏

High mannose level in bladder cancer enhances type 1 fimbria-mediated attachment of uropathogenic E. coli

膀胱癌中高甘露糖水平增强 1 型菌毛介导的泌尿道致病性大肠杆菌的附着

期刊:Frontiers in Cellular and Infection Microbiology
影响因子:4.6
doi:10.3389/fcimb.2022.968739
Naseem Maalouf, Chamutal Gur, Vladimir Yutkin, Viviana Scaiewicz, Ofer Mandelboim, Gilad Bachrach
肿瘤
膀胱癌
发表日期：2022
文献求助 收藏

Adsorption of Polar Species at Crude Oil-Water Interfaces: the Chemoelastic Behavior

极性物质在原油-水界面上的吸附：化学弹性行为

期刊:Langmuir
影响因子:3.9
doi:10.1021/acs.langmuir.2c00058
Saad, Ahmed M; Aime, Stefano; Chandra Mahavadi, Sharath; Song, Yi-Qiao; Yutkin, Maxim P; Weitz, David; Patzek, Tadeusz W
发表日期：2022
文献求助 收藏

False Positive Findings of [(18)F]PSMA-1007 PET/CT in Patients After Radical Prostatectomy with Undetectable Serum PSA Levels

根治性前列腺切除术后血清PSA水平无法检测的患者中[(18)F]PSMA-1007 PET/CT出现假阳性结果

期刊:Frontiers in Surgery
影响因子:1.8
doi:10.3389/fsurg.2022.943760
Orevi, Marina; Ben-Haim, Simona; Abourbeh, Galith; Chicheportiche, Alexandre; Mishani, Eyal; Yutkin, Vladimir; Gofrit, Ofer N
PSA
发表日期：2022
文献求助 收藏

Real-world Israeli single institution experience with PET-PSMA for staging of patients with clinically staged localized prostate carcinoma

以色列某单一机构应用PET-PSMA对临床分期局限性前列腺癌患者进行分期的真实世界经验

期刊:Cancer Reports
影响因子:1.9
doi:10.1002/cnr2.1386
Zarbiv, Yonaton; Peerless, Yehudit; Wygoda, Marc; Orevi, Marina; Meir, Karen; Gofrit, Ofer N; Yutkin, Vladimir; Frank, Stephen
肿瘤
前列腺癌
肿瘤免疫
发表日期：2021
文献求助 收藏

Finding the way into the darkness. A unique endourologic realignment to treat a complete disruption of the posterior urethra to a 7 years old boy. A case report

探寻黑暗之路：一例独特的腔内泌尿外科手术，用于治疗一名7岁男孩的后尿道完全断裂。病例报告

期刊:Urology Case Reports
影响因子:0.4
doi:10.1016/j.eucr.2020.101501
A, Lorber; S, Roizman; I, Leotsakos; V, Yutkin; G, Hidas; On, Gofrit; Eh, Landau; M, Duvdevani
发表日期：2021
文献求助 收藏

Trimodal therapy in T2-4aN0M0 bladder cancer--How to select the best candidate?

T2-4aN0M0期膀胱癌的三联疗法——如何选择最佳候选患者？

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.3478
Gofrit, Ofer N; Meirovitz, Amichay; Frank, Stephen; Rabinovich, Igal; Luwisch, Hemda; Yutkin, Vladimir; Neuman, Tzahi; Hidas, Guy; Duvdevani, Mordechai; Wygoda, Marc
肿瘤
肿瘤免疫
膀胱癌
发表日期：2020
文献求助 收藏